Welcome to the
Hepatitis B Foundation
India Launches Drive to Eradicate Hepatitis B Virus
Nov 30 – The health ministry in collaboration with UNICEF launched a media campaign, including megastar Amitabh Bachchan, with the resolve to make India Hepatitis B Virus-free by the next decade. Read more.
Functional Liver Cells Grown in the Lab
Nov 30 – Researchers have developed a new technique for growing human liver cells in the laboratory, described as the “holy grail of liver research”, and would allow for a more efficient, lower cost means of studying viral hepatitis, liver cancer, fatty liver, and drug toxicity. Read more.
Coffee Linked to Reduced Liver Fibrosis in People with HBV, HCV, and NAFLD
Nov 30 – Drinking coffee was associated with lower liver stiffness, a non-invasive measure used to estimate liver fibrosis, in people with hepatitis B, hepatitis C, and non-alcoholic fatty liver disease (NAFLD). Read more.
Summary of Liver Cancer Workshop Hosted by Hepatitis B Foundation Published in JNCI Journal of the National Cancer Institute
Dec. 1 - The Hepatitis B Foundation invited 25 of the nation's leaders in liver cancer to identify gaps and limitations in current approaches to the detection and treatment of HCC and to define research priorities and opportunities for advocacy. Participants agreed that primary prevention of liver cancer relies on prevention and treatment of viral hepatitis and other underlying etiologies. The Foundation's summary of the workshop has now been published by the NCI of the National Institutes of Health. Read the entire article.
Liver cancer is Preventable Twitter Chat Storify Available
Oct 26- Did you miss last week’s twitter chat with HBF, NVHR and Dr. Robert Gish? Check out the conversation with the Storify transcript of the chat by CDCNPIN. Read more.
Listen to Dr. W. Thomas London Interviewed by the American Society for Microbiology. (Courtesy of Principles of Virology, 4th edition, ISBN 978-1-55581-951-4, ©2015 by American Society for Microbiology Press, Oct. 2015.) Watch now.
The W. Thomas London Distinguished Professorship Established by the Hepatitis B Foundation and Baruch S. Blumberg Institute
Oct 5 - The named Professorship honors Dr. W. Thomas London (on left) who made transformational contributions to the discovery of the hepatitis B virus with Dr. Baruch Blumberg and dedicated his career to the study of the virus and care of those affected. Dr. Ju Tao Guo (on right) is the inaugural recipient of the new professorship. He serves as director of Experimental Therapeutics at the Baruch S. Blumberg Institute. Read more.
Page last modified December 1, 2015